MCID: DBT002
MIFTS: 42

Diabetic Autonomic Neuropathy malady

Categories: Neuronal diseases

Aliases & Classifications for Diabetic Autonomic Neuropathy

Aliases & Descriptions for Diabetic Autonomic Neuropathy:

Name: Diabetic Autonomic Neuropathy 12 52 14 69
Diabetic Neuropathies 42 69

Classifications:



External Ids:

Disease Ontology 12 DOID:11503
MeSH 42 D003929
NCIt 47 C27068
SNOMED-CT 64 50620007
UMLS 69 C0271686

Summaries for Diabetic Autonomic Neuropathy

MalaCards based summary : Diabetic Autonomic Neuropathy, also known as diabetic neuropathies, is related to diabetic neuropathy and microvascular complications of diabetes 1, and has symptoms including neuralgia and sciatica. An important gene associated with Diabetic Autonomic Neuropathy is AKR1B1 (Aldo-Keto Reductase Family 1 Member B), and among its related pathways/superpathways are PI3K-Akt signaling pathway and p75(NTR)-mediated signaling. The drugs Nabilone and Quinapril have been mentioned in the context of this disorder. Affiliated tissues include heart, testes and skin, and related phenotypes are behavior/neurological and cardiovascular system

Related Diseases for Diabetic Autonomic Neuropathy

Diseases related to Diabetic Autonomic Neuropathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
id Related Disease Score Top Affiliating Genes
1 diabetic neuropathy 12.4
2 microvascular complications of diabetes 1 11.4
3 autonomic neuropathy 10.9
4 neuropathy 10.9
5 postural hypotension 10.2
6 breast fibroadenoma 10.2 INS NTF3
7 dacryoadenitis 10.2 EPO INS
8 agammaglobulinemia 6 10.2 AKR1B1 INS
9 basal ganglia cerebrovascular disease 10.1 EPO INS
10 pancreatitis 10.1
11 hypoglycemia 10.1
12 shaken baby syndrome 10.0 DBH INS
13 mucopolysaccharidosis 9.9 AKR1B1 NGF NTF3
14 petrositis 9.9 DBH EPO
15 tracheitis 9.9 AOC1 NGF
16 iritis 9.9
17 sudden cardiac death 9.9
18 pythiosis 9.9 DBH EPO
19 familial spastic paralysis 9.9 DBH NGF
20 c5 deficiency 9.9 DBH NGF
21 cytomegalic congenital adrenal hypoplasia 9.9 DBH INS
22 senile angioma 9.8 NGF NTF3
23 myocardial infarction 9.8
24 hemopericardium 9.8 DBH INS NGF
25 fissured tongue 9.7 AKR1B1 EPO INS NGF NTF3
26 pheochromocytoma 9.7
27 vascular disease 9.7
28 neuroblastoma 9.7
29 gastric dilatation 9.7
30 cerebritis 9.7
31 obesity 9.7
32 insulin-like growth factor i 9.7
33 reflex sympathetic dystrophy 9.7
34 cardiomyopathy 9.7
35 acute myocardial infarction 9.7
36 autonomic dysfunction 9.7
37 artery disease 9.7
38 dysautonomia 9.7
39 peripheral artery disease 9.7
40 hypoxia 9.7
41 atrial fibrillation 9.7
42 mucositis 9.7
43 esophagitis 9.7
44 dilated cardiomyopathy 9.7 AKR1B1 EPO INS NGF NTF3
45 rumination disorder 8.8 AKR1B1 AOC1 DBH EPO INS MLNR

Graphical network of the top 20 diseases related to Diabetic Autonomic Neuropathy:



Diseases related to Diabetic Autonomic Neuropathy

Symptoms & Phenotypes for Diabetic Autonomic Neuropathy

UMLS symptoms related to Diabetic Autonomic Neuropathy:


neuralgia, sciatica

MGI Mouse Phenotypes related to Diabetic Autonomic Neuropathy:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.91 AKR1B1 AOC1 DBH INS NGF NTF3
2 cardiovascular system MP:0005385 9.8 AOC1 DBH EPO INS NGF NTF3
3 homeostasis/metabolism MP:0005376 9.8 NGF NTF3 AKR1B1 AOC1 DBH EPO
4 muscle MP:0005369 9.55 EPO INS NGF NTF3 SYNM
5 normal MP:0002873 9.35 DBH EPO INS NGF NTF3
6 vision/eye MP:0005391 9.1 AKR1B1 AOC1 DBH INS NGF NTF3

Drugs & Therapeutics for Diabetic Autonomic Neuropathy

Drugs for Diabetic Autonomic Neuropathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 176)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nabilone Approved, Investigational Phase 4,Phase 3 51022-71-0 5284592
2
Quinapril Approved, Investigational Phase 4 85441-61-8 54892
3
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2 148553-50-8 5486971
4
Cilostazol Approved Phase 4 73963-72-1 2754
5
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
6
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
7
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
8
Dopamine Approved Phase 4,Phase 2 51-61-6, 62-31-7 681
9
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
11 Antihypertensive Agents Phase 4,Phase 3,Phase 2
12 HIV Protease Inhibitors Phase 4,Phase 2
13
protease inhibitors Phase 4,Phase 2
14 Analgesics Phase 4,Phase 3,Phase 2
15 Anti-Anxiety Agents Phase 4,Phase 3,Phase 2
16 Anticonvulsants Phase 4,Phase 3,Phase 2
17 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
18 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
19 Psychotropic Drugs Phase 4,Phase 3,Phase 2
20 Tranquilizing Agents Phase 4,Phase 3,Phase 2
21 Antiemetics Phase 4,Phase 3,Phase 2
22 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
23 Gastrointestinal Agents Phase 4,Phase 3,Phase 2
24 Fibrinolytic Agents Phase 4,Phase 1
25 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1
26 Anesthetics Phase 4,Phase 3,Phase 2
27 Excitatory Amino Acid Antagonists Phase 4,Phase 3
28 Excitatory Amino Acids Phase 4,Phase 3
29 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Hormone Antagonists Phase 4,Phase 3,Phase 2
31 Hormones Phase 4,Phase 3,Phase 2
32 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
33 Angiotensin-Converting Enzyme Inhibitors Phase 4
34 calcium channel blockers Phase 4,Phase 3,Phase 2
35 Calcium, Dietary Phase 4,Phase 3,Phase 2
36 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1
37 Bronchodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Neuroprotective Agents Phase 4
39 Phosphodiesterase 3 Inhibitors Phase 4
40 Phosphodiesterase Inhibitors Phase 4,Phase 2
41 Platelet Aggregation Inhibitors Phase 4
42 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
43 Vasodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
44 Anesthetics, Local Phase 4,Phase 2
45 Anti-Arrhythmia Agents Phase 4
46 Antimanic Agents Phase 4
47 Antiparkinson Agents Phase 4
48 Diuretics, Potassium Sparing Phase 4
49 GABA Agents Phase 4
50
gamma-Aminobutyric Acid Phase 4 56-12-2 119

Interventional clinical trials:

(show top 50) (show all 79)
id Name Status NCT ID Phase
1 Inspiratory Muscle Training in Patients With Autonomic Neuropathic Unknown status NCT00752440 Phase 4
2 Bi-Axial Rotating Magnetic Field Therapy in Refractory Neuropathic Foot Pain Secondary to Diabetic Peripheral Neuropathy Unknown status NCT00123136 Phase 4
3 Efficacy of Administration of ACE-Inhibition on Autonomic and Peripheral Neuropathy in Patients With Diabetes Mellitus Completed NCT03031834 Phase 4
4 Autonomic Nervous System Dysfunction and Peripheral Neuropathy in a Cohort of Asymptomatic Juvenile Diabetic Patients (Type I): A Case-Controlled Study Completed NCT00466778 Phase 4
5 A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy Completed NCT00573261 Phase 4
6 Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy Completed NCT00380913 Phase 4
7 Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines Completed NCT01076478 Phase 4
8 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4
9 Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects Recruiting NCT02682901 Phase 4
10 Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease Not yet recruiting NCT02339142 Phase 4
11 Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain Unknown status NCT01035281 Phase 3
12 Diabetic Neuropathy Topical Treatment Unknown status NCT00661063 Phase 3
13 An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes Completed NCT00116207 Phase 3
14 Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) Completed NCT00594152 Phase 3
15 Fluid Retention in Rosiglitazone Treated Subjects With Autonomic Neuropathy. Completed NCT00422955 Phase 3
16 Efficacy and Safety Study of Pregabalin in the Treatment of Pain on Walking in Patients With Diabetic Peripheral Neuropathy (DPN) Completed NCT01474772 Phase 3
17 Effect Of Pregabalin Treatment In Patients With Diabetic Nerve Pain Who Currently Use A Non-Steroid Anti-Inflammatory Drug (NSAID) For Another Pain Completed NCT01455415 Phase 3
18 Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis Completed NCT00409175 Phase 2, Phase 3
19 Clinical Trial for the Treatment of Diabetic Foot Ulcers Using a Nitric Oxide Releasing Patch: PATHON Completed NCT00428727 Phase 3
20 Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy Recruiting NCT03050827 Phase 3
21 The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Who Have Already Been Treated With ALN-TTR02 (Patisiran) Enrolling by invitation NCT02510261 Phase 3
22 Acetylcholinesterase Inhibition and Orthostatic Hypotension in SC I Unknown status NCT02307526 Phase 2
23 Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy Completed NCT01452113 Phase 2
24 Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral Neuropathy Completed NCT00760955 Phase 2
25 A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain Completed NCT01345045 Phase 2
26 Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors Completed NCT00010751 Phase 2
27 Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy Completed NCT00695565 Phase 2
28 Safety and Efficacy Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy Completed NCT02068027 Phase 2
29 A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy Completed NCT02355158 Phase 2
30 The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy Completed NCT02643251 Phase 2
31 A Study on the Safety and Efficacy of Nitric Oxide Gel in Subjects With Painful Diabetic Neuropathy Completed NCT01633086 Phase 2
32 Effects of Moxaverine and Placebo on Ocular Blood Flow Completed NCT00709423 Phase 2
33 Nitric Oxide Generating Gel Dressing in Patients With Diabetic Foot Ulcers Completed NCT01982565 Phase 1, Phase 2
34 Improving Autonomic Function and Balance in Diabetic Neuropathy Recruiting NCT01864460 Phase 2
35 Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis Recruiting NCT01557296 Phase 2
36 The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes Not yet recruiting NCT02915263 Phase 2
37 A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy Terminated NCT00993018 Phase 2
38 Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers Terminated NCT00316537 Phase 1, Phase 2
39 A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115) Withdrawn NCT00837941 Phase 2
40 Effect of Local Application of Boron on Diabetic Foot Ulcers Unknown status NCT02087215 Phase 1
41 A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes Unknown status NCT01822431
42 The Relationship Between Vascular Adhesion Protein-1 and Diabetic Cardiovascular Autonomic Neuropathy Unknown status NCT01706289
43 Sleep Apnea in Type 1 Diabetes Unknown status NCT01935765 Early Phase 1
44 Effect of DPP-IV Inhibitor on Glycemic Control and Autonomic Neuropathy in Adult Patients With Diabetes Mellitus Unknown status NCT01545024
45 Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. Unknown status NCT00155142
46 The Relative Prevalence and Severity of Autonomic Nervous System Dysfunction Completed NCT00919347
47 Coronary Blood Flow Regulation During General Anesthesia Completed NCT00866801
48 NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes Completed NCT01707979
49 Pyridostigmine and Its Effects on Autonomic Modulation in Diabetic Patients Completed NCT00953914
50 Evaluation of Exenatide in Patients With Diabetic Neuropathy Completed NCT00855439

Search NIH Clinical Center for Diabetic Autonomic Neuropathy

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: diabetic neuropathies

Genetic Tests for Diabetic Autonomic Neuropathy

Anatomical Context for Diabetic Autonomic Neuropathy

MalaCards organs/tissues related to Diabetic Autonomic Neuropathy:

39
Heart, Testes, Skin, Eye, Brain, Pancreatic Islet

Publications for Diabetic Autonomic Neuropathy

Articles related to Diabetic Autonomic Neuropathy:

(show top 50) (show all 289)
id Title Authors Year
1
Inspiratory muscle training in patients with diabetic autonomic neuropathy: a randomized clinical trial. ( 25982993 )
2015
2
Role of Microcirculatory Disturbances and Diabetic Autonomic Neuropathy in Takotsubo Cardiomyopathy. ( 26468716 )
2015
3
Morphologic Changes in Autonomic Nerves in Diabetic Autonomic Neuropathy. ( 26706915 )
2015
4
Association of diabetic autonomic neuropathy with red blood cell aldose reductase activity. ( 24485209 )
2014
5
CORNEAL confocal microscopy for the diagnosis of diabetic autonomic neuropathy. ( 25556884 )
2014
6
Disproportionate pupillary involvement in diabetic autonomic neuropathy. ( 25377131 )
2014
7
Diabetic autonomic neuropathy. ( 25410215 )
2014
8
Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. ( 24026548 )
2013
9
Diabetic autonomic neuropathy. ( 24095132 )
2013
10
Highlights in clinical autonomic neuroscience: latest developments in the early detection of diabetic autonomic neuropathy. ( 22306250 )
2012
11
Mortality after acute myocardial infarction: significance of cardiovascular diabetic autonomic neuropathy (CDAN). ( 23097964 )
2012
12
Diabetic autonomic neuropathy. ( 23393679 )
2012
13
The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation. ( 22291825 )
2011
14
The relationship between diabetic autonomic neuropathy and diabetic risk factors in a Taiwanese population. ( 21986117 )
2011
15
Vasopressin release induced by hypothension is blunted in patients with diabetic autonomic neuropathy. ( 20370555 )
2011
16
Severe orthostatic hypotension in a diabetic patient may not be due to diabetic autonomic neuropathy. ( 21902089 )
2011
17
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. ( 21247746 )
2011
18
Gastric mucosal nerve density: a biomarker for diabetic autonomic neuropathy? ( 20837965 )
2010
19
Different effects of diabetic autonomic neuropathy on regional transcutaneous oxygen tension in patients with peripheral arterial disease. ( 21466127 )
2010
20
Effect of acute hyperglycaemia on sensory processing in diabetic autonomic neuropathy. ( 20624170 )
2010
21
Cough reflex sensitivity in adolescents with diabetic autonomic neuropathy. ( 20156724 )
2009
22
A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. ( 20046691 )
2009
23
New insights in diabetic autonomic neuropathy in children and adolescents. ( 19734243 )
2009
24
The impact of diabetic autonomic neuropathy on the incretin effect. ( 18376350 )
2008
25
Dynamic cerebral autoregulation assessment using chaotic analysis in diabetic autonomic neuropathy. ( 17874153 )
2008
26
Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. ( 17967455 )
2008
27
Gut sensations in diabetic autonomic neuropathy. ( 17521809 )
2007
28
Ergotamine use in severe diabetic autonomic neuropathy. ( 17227338 )
2007
29
Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy. ( 16389160 )
2006
30
Severe orthostatic hypotension with diabetic autonomic neuropathy successfully treated with a beta(1)-blocker: a case report. ( 16810280 )
2006
31
Ergotamine use in severe diabetic autonomic neuropathy. ( 16681568 )
2006
32
Acute dysautonomia: a rare manifestation of diabetic autonomic neuropathy masquerading as pheochromocytoma. ( 16279988 )
2005
33
Images in clinical medicine. Gastric dilatation secondary to diabetic autonomic neuropathy. ( 16371635 )
2005
34
Diabetic autonomic neuropathy: evidence for apoptosis in situ in the rat. ( 15198656 )
2004
35
Severe and disabling diabetic autonomic neuropathy: a case report. ( 15120708 )
2004
36
Pupillography refines the diagnosis of diabetic autonomic neuropathy. ( 15240199 )
2004
37
Diabetic autonomic neuropathy. ( 15088257 )
2003
38
Use of heart rate reserve and rating of perceived exertion to prescribe exercise intensity in diabetic autonomic neuropathy. ( 12663561 )
2003
39
Diabetic autonomic neuropathy: importance of its early detection for improving morbidity and mortality. ( 12879940 )
2003
40
Diagnosis of diabetic autonomic neuropathy: a multivariate approach. ( 12864779 )
2003
41
Diabetic autonomic neuropathy is associated with an increased incidence of strokes. ( 14614967 )
2003
42
Diabetic autonomic neuropathy. ( 12716821 )
2003
43
Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. ( 14578206 )
2003
44
Comparative neuropathology and diabetic autonomic neuropathy. ( 14578168 )
2003
45
The effectiveness of treatments of diabetic autonomic neuropathy is not the same in autonomic nerves supplying different organs. ( 12502507 )
2003
46
Does diabetic autonomic neuropathy influence the clinical manifestations of reflux esophagitis? ( 14604253 )
2003
47
Diagnosis and management of diabetic autonomic neuropathy. ( 14606343 )
2003
48
Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy. ( 12819007 )
2003
49
Resolution of diabetic autonomic neuropathy. ( 12151692 )
2002
50
Neuropathology and pathogenesis of diabetic autonomic neuropathy. ( 12198813 )
2002

Variations for Diabetic Autonomic Neuropathy

Expression for Diabetic Autonomic Neuropathy

Search GEO for disease gene expression data for Diabetic Autonomic Neuropathy.

Pathways for Diabetic Autonomic Neuropathy

Pathways related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.87 EPO INS NGF
2
Show member pathways
11.08 NGF NTF3
3
Show member pathways
10.74 NGF NTF3
4 10.3 EPO INS

GO Terms for Diabetic Autonomic Neuropathy

Cellular components related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.35 AKR1B1 AOC1 DBH EPO INS
2 extracellular region GO:0005576 9.1 AOC1 DBH EPO INS NGF NTF3

Biological processes related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cell-cell signaling GO:0007267 9.54 INS NGF NTF3
2 neuron projection morphogenesis GO:0048812 9.4 NGF NTF3
3 positive regulation of DNA replication GO:0045740 9.32 EPO INS
4 acute-phase response GO:0006953 9.26 EPO INS
5 activation of protein kinase B activity GO:0032148 9.16 INS NTF3
6 regulation of neuron differentiation GO:0045664 8.96 NGF NTF3
7 positive regulation of Ras protein signal transduction GO:0046579 8.62 EPO NGF

Molecular functions related to Diabetic Autonomic Neuropathy according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 copper ion binding GO:0005507 8.62 AOC1 DBH

Sources for Diabetic Autonomic Neuropathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....